For Alzheimer's patients, there's a new possible w
Post# of 157708

https://enews.wvu.edu/files/d/17caa526-41dc-4...-times.pdf
My question is - since Leronlimab is considered a "large" molecule antibody, how does it cross the blood-brain barrier when only 1% of other drugs (like aducanumab) get through?

